Class II · Moderate risk
Fondaparinux Sodium Injection
Subpotent Drug: Out of specification for assay
National Drug Code
Is NDC 55150-0232-00 recalled?
Fondaparinux Sodium
Yes — this exact package was recalled
1 FDA recall names the code 55150-0232-00 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.
- Active ingredient
- Fondaparinux Sodium
- Strength
- FONDAPARINUX SODIUM 7.5 mg/.6mL
- Form
- Injection, Solution · Subcutaneous
- Labeler
- Eugia US LLC
- Type
- Human Prescription Drug
- Product code
- 55150-0232
Recalls naming this package
Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.
Other recalled products from this labeler
- 55150-0120 Piperacillin and Tazobactam 2
- 55150-0183 Nicardipine Hydrochloride 2
- 55150-0202 Pantoprazole Sodium 2
- 55150-0242 Linezolid 2
- 55150-0243 Levofloxacin 2
- 55150-0306 Progesterone 2
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.